Assessment of Lacrijet monocanalicular intubation for congenital nasolacrimal duct obstruction

Abstract

Purpose

To assess the success rate and complications of Lacrijet monocanalicular stent (FCI S.A.S, Paris, France) intubation in children treated for congenital nasolacrimal duct obstruction (CNLDO).

Methods

Retrospective review study which included children with CNLDO that were intubated with Lacrijet monocanalucilar silicone tube.The Lacrijet tube remained in place for 11–15 weeks post operatively and was removed in the clinic with topical anesthesia. Operative time was recorded for each case. All children were evaluated using the following parameters preoperatively and postoperatively: tear meniscus height, Fluorescein dye disappearance test (FDDT), and MUNK score.

Results

The study included 20 eyes with mean age of 26.25 ± 11.25 months. 17 eyes (85%) had undergone probing previously. Mean operation time of Lacrijet intubation was 8.5 min (95% CI 7.04–9.95). Mean follow-up period was 204.65 ± 105.27 days. Lacrijet intubation resulted in statistically significant improvements in tear meniscus height (P < .001), FDDT (P < 0.001), and MUNK score (P < 0.001) in all children. Two different sizes of Lacrijet intubations were used. Complete success was obtained in all cases. No complications were observed.

Conclusions

Lacrijet lacrimal intubation has a high rate of success, shortens surgical time and has a low rate of complications in children with CNLDO.

Keywords

Congenital nasolacrimal duct obstruction Lacrijet lacrimal intubation monocanalicular intubation epiphora

Get full access to this article

View all access options for this article.

References

Guerry

III Kendig

Jr . Congenital impotency of the nasolacrimal duct. Arch Ophthalmol 1948; 39: 193–204.

Paul

Shepherd

. Congenital nasolacrimal duct obstruction: natural history and the timing of optimal intervention. J Pediatr Ophthalmol Strabismus 1994; 31: 362–367.

Casady

Meyer

Simon

, et al. Stepwise treatment paradigm for congenital nasolacrimal duct obstruction. Ophthal Plast Reconstr Surg 2006; 22: 243–247.

Katowitz

Welsh

. Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction. Ophthalmology 1987; 94: 698–705.

Lee

Ahn

Lee

, et al. Clinical effectiveness of monocanalicular and bicanalicular silicone intubation for congenital nasolacrimal duct obstruction. J Craniofac Surg 2012; 23: 1010–1014.

Kominek

Cervenka

Pniak

, et al. Monocanailcular versus bincanalicular intubation in the treatment of congenital nasolacrimal duct obstruction. Graefes Arch Clin Exp Ophthalmol 2011; 249: 1729–1733.

Eshraghi

Jamshidian-Tehrani

Mirmohammadsadeghi

. Comparison of the success rate between monocanalicular and bicanalicular intubations in incomplete complex congenital nasolacrimal duct obstruction. Orbit 2017; 36: 215–217.

Doughty

Laiquzzaman

Oblak

, et al.

The tear (lacrimal) meniscus height in human eyes: a useful clinical measure or an unusable variable sign?

Cont Lens Anterior Eye 2002; 25: 57–65.

Kashkouli

Mirzajani

Jasmshidian-Tehrani

, et al. Reliability of fluorescein dye disappearance test in assessment of adults with nasolacrimal duct obstruction. Ophthalal Plast Reconstr Surg 2013; 29: 167–169.

10.

Munk

Lin

Morris

. Epiphora: treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drainage apparatus. Radiology 1990; 177: 687–690.

11.

Khatib

Nazemzadeh

Revere

, et al. Use of the Masterka for complex nasolacrimal duct obstruction in children. J AAPOS 2017; 21: 380–383.

12.

Andalib

Gharabaghi

Nabai

, et al. Monocanalicular versus bicanalicular silicone intubation for congenital nasolacrimal duct obstruction. J AAPOS 2010; 14: 421–424.

13.

Fayet

Racy

Ruban

, et al. Preloaded monoka (Lacrijet) and congenital nasolacrimal duct obstruction: initial results. J Fr Ophthalmol 2021; 44: 670–679.

14.

Mihailovic

Grenzebach

Eter

, et al. Application possibilities of a new preloaded nasolacrimal duct intubation system. Klin Monbl Augenheilkd 2021; 238: 48–54.

15.

Ratliff

Meyer

Silicone intubation without intranasal fixation for treatment of congenital nasolacrimal duct obstruction. Am J Ophthalmol 1994; 118: 781–785.

16.

A-Hussain

Nasr

. Silastic intubation in congenital nasolacrimal duct obstruction: a study of 129 eyes. Ophthal Plast Reconstr Surg 1993; 9: 32–37.

17.

Migliori

Putterman

. Silicone intubation for the treatment of congenital lacrimal duct obstruction: successful results removing the tubes after six weeks. Ophthalmology 1998; 95: 792–795.

18.

Kaufman

Guay-Bhatia

LAG

. Monocanalicular intubation with monoka tubes for the treatment of congenital nasolacrimal duct obstruction. Ophthalmology 1998; 105: 336–341.

19.

Fayet

Racy

Katowitz

, et al. Insertion of a preloaded Monoka stent for congenital nasolacrimal obstruction: intraoperative observations. A preliminary study. J Fr Ophthalmol 2019; 42: 248–254.

20.

Wallace

Cox

White

, et al. Endoscopic-assisted probing for congenital nasolacrimal duct obstruction. Eye 2006; 20: 998–1003.

21.

Gupta

Neeraj

Smriti

, et al. A comparison of the success rated of endoscopic assisted probing in the treatment of membranous congenital nasolacrimal duct obstruction between younger and older children and its correlation with the thickness of the membrane at the Valve of Hasner. Orbit 2018; 37: 257–261.

22.

Vinciguerra

Nonis

Resti

, et al. Best treatment available for distal acquired lacrimal obstruction: a systematic review and meta-analysis. Clin Otolaryngol 2020; 45: 545–557.